Note 3 - Acquisitions (Tables)

9 Months Ended

Sep. 30, 2021

Notes Tables

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Merger consideration shares		530,502
BioLife stock price (as of September 1, 2021)	$	60.50
Value of issued shares	$	32,095
plus: Fair value of BioLife’s existing investment in Sexton	$	7,951
less: Net working capital adjustment	$	(118	)
Merger Consideration	$	39,928

BioLife shares outstanding (as of March 19, 2021)		33,401,359
Merger consideration percentage		19.9	%
Merger consideration shares		6,646,870
less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI		10,400
Subtotal		6,636,470
BioLife stock price (as of May 3, 2021)	$	35.07
Value of issued shares	$	232,741
plus: Settlement of BioLife prepaid deposits	$	2,152
plus: Net settlement of BioLife accounts receivable	$	16
Merger Consideration	$	234,909

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Cash	$	1,516
Accounts receivable, net		492
Inventory		1,310
Prepaid expenses and other current assets		670
Property, plant and equipment, net		737
Operating lease right-of-use assets, net		470
Developed technology		4,132
Customer relationships		2,276
Tradenames		2,324
Non-compete agreements		90
Goodwill		28,273
Accounts payable		(291	)
Lease liabilities, operating		(470	)
Deferred tax liability		(1,284	)
Other liabilities		(317	)
Fair value of net assets acquired	$	39,928

Cash	$	43
Accounts receivable, net		7,076
Inventory		15,547
Prepaid expenses and other current assets		639
Property, plant and equipment, net		3,512
Operating lease right-of-use assets, net		1,741
Financing lease right-of-use assets, net		114
Long-term deposits and other assets		4
Developed technology		18,140
Customer relationships		7,020
Tradenames		26,640
Non-compete agreements		1,240
In-process research and development		67,440
Goodwill		137,215
Accounts payable		(9,837	)
Line of credit		(4,231	)
Lease liabilities, operating		(1,880	)
Lease liabilities, financing		(114	)
Long-term debt		(4,410	)
Deferred tax liability		(23,526	)
Other liabilities		(7,464	)
Fair value of net assets acquired	$	234,909

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

	Fair Value		Useful Life (Years)
Developed technology	$	4,132	5	-	9
Customer relationships		2,276		2
Tradenames		2,324		11
Non-compete agreements		90		1
Total identifiable intangible assets	$	8,822

	Fair Value		Useful Life (Years)
Developed technology	$	18,140		6
Customer relationships		7,020		12
Tradenames		26,640		15
Non-compete agreements		1,240		4
In-process research and development		67,440		N/A
Total identifiable intangible assets	$	120,480

Business Acquisition, Pro Forma Information [Table Text Block]

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(In thousands)	2021 (unaudited)			2020 (unaudited)			2021 (unaudited)		2020 (unaudited)
Total revenue	$	34,524		$	11,697		$	85,189	$	34,707
Net (loss) income	$	(685	)	$	(1,850	)	$	4,612	$	2,056

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
(In thousands)	2021 (unaudited)		2020 (unaudited)			2021 (unaudited)			2020 (unaudited)
Total revenue	$	33,800	$	21,204		$	106,427		$	58,056
Net income (loss)	$	79	$	(3,393	)	$	(1,939	)	$	4,912